Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
25.05.2023 10:31:50

Managers’ transactions

May 25,2023 

Announcement no. 32 

Managers’ transactions? 

Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in Pharma Equity Group A/S made by persons discharging managerial responsibilities in Pharma Equity Group and/or persons closely related with them.?? 

 
  
1. Details of the person discharging managerial responsibilities/person closely associated? 

a) Name? 
  
Thomas Kaas Selsø 

2. Reason for the notification? 

 a) Position/status? 
 
CEO 
  
b) Initial notification/amendment? 
  
Initial notification? 
 
3. Details of the issuer? 
  
a) Name? 
 
Pharma Equity Group A/S? 
   
b) LEI? 
 
 2138008SUI4D917FKN20   
 
c) Trade name 
  
PEG 
  
4. Details of the transaction(s)? 
  
a) Description of the financial instrument, type??  of instrument?and Identification code? 
 
Shares, ISIN code DK0061155009 
  
b) Nature of the transaction? 
 
Purchase? 
  
c) Price(s) and volume(s)? 

Price: DKK 167,225

Volume: 551,724? 
   
d) Aggregated information? 
- Aggregated volume? 
- Aggregated price? 
 
N/A? 
  
e) Date of the transaction? 
  
25-05-2023, 09:26 CEST 
 
 f) Place of the transaction? 
 
Nasdaq Copenhagen A/S 



For further information, please contact:

Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14 

Peter M. Eriksen, Chair of the Board of Directors of Pharma Equity Group A/S, phone: 51 99 66 00. 


Analysen zu Pharma Equity Group A-S Registered Shs -Amehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel